Revolution Medicines Inc (NASDAQ: RVMD) on Friday, soared 5.23% from the previous trading day, before settling in for the closing price of $64.38. Within the past 52 weeks, RVMD’s price has moved between $29.17 and $66.11.
Annual sales at Healthcare sector company slipped by -27.80% over the past five years. The company achieved an average annual earnings per share of -56.93%. With a float of $167.70 million, this company’s outstanding shares have now reached $189.71 million.
Revolution Medicines Inc (RVMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Revolution Medicines Inc is 13.25%, while institutional ownership is 88.47%. The most recent insider transaction that took place on Nov 12 ’25, was worth 1,301,410. In this transaction an insider of this company sold 20,000 shares at a rate of $65.07, taking the stock ownership to the 247,863 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Chief Financial Officer sold 10,000 for $64.00, making the entire transaction worth $640,000. This insider now owns 110,994 shares in total.
Revolution Medicines Inc (RVMD) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.12 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.96) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -56.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -16.43% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Revolution Medicines Inc (RVMD) is currently performing well based on its current performance indicators. A quick ratio of 8.05 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.18, a number that is poised to hit -1.59 in the next quarter and is forecasted to reach -6.31 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Revolution Medicines Inc (NASDAQ: RVMD) saw its 5-day average volume 2.99 million, a positive change from its year-to-date volume of 1.98 million. As of the previous 9 days, the stock’s Stochastic %D was 89.54%.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 96.37%, which indicates a significant increase from 89.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.41 in the past 14 days, which was higher than the 1.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.19, while its 200-day Moving Average is $41.69. Nevertheless, the first resistance level for the watch stands at $70.01 in the near term. At $72.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $75.53. If the price goes on to break the first support level at $64.49, it is likely to go to the next support level at $61.24. The third support level lies at $58.97 if the price breaches the second support level.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
Market capitalization of the company is 13.10 billion based on 193,320K outstanding shares. Right now, sales total 0 K and income totals -600,090 K. The company made 0 K in profit during its latest quarter, and -305,210 K in sales during its previous quarter.
